Astria Therapeutics Statistics

Total Valuation

ATXS has a market cap or net worth of $300.79 million. The enterprise value is -$1.10 million.

Market Cap	300.79M
Enterprise Value	-1.10M

Important Dates

The last earnings date was Tuesday, March 11, 2025, before market open.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

ATXS has 56.43 million shares outstanding. The number of shares has increased by 86.44% in one year.

Current Share Class	56.43M
Shares Outstanding	56.43M
Shares Change (YoY)	+86.44%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	64.63%
Float	33.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.44
P/TBV Ratio	1.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.49, with a Debt / Equity ratio of 0.02.

Current Ratio	17.49
Quick Ratio	17.15
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.52% and return on invested capital (ROIC) is -24.55%.

Return on Equity (ROE)	-33.52%
Return on Assets (ROA)	-23.36%
Return on Invested Capital (ROIC)	-24.55%
Return on Capital Employed (ROCE)	-34.51%
Revenue Per Employee	n/a
Profits Per Employee	-$1.21M
Employee Count	78
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.09% in the last 52 weeks. The beta is 0.68, so ATXS's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-58.09%
50-Day Moving Average	6.82
200-Day Moving Average	9.62
Relative Strength Index (RSI)	33.36
Average Volume (20 Days)	282,697

Short Selling Information

The latest short interest is 3.19 million, so 5.66% of the outstanding shares have been sold short.

Short Interest	3.19M
Short Previous Month	3.18M
Short % of Shares Out	5.66%
Short % of Float	9.40%
Short Ratio (days to cover)	13.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-111.56M
Pretax Income	-81.63M
Net Income	-94.26M
EBITDA	n/a
EBIT	-111.56M
Earnings Per Share (EPS)	-$1.68

Full Income Statement

Balance Sheet

The company has $328.13 million in cash and $5.35 million in debt, giving a net cash position of $322.78 million or $5.72 per share.

Cash & Cash Equivalents	328.13M
Total Debt	5.35M
Net Cash	322.78M
Net Cash Per Share	$5.72
Equity (Book Value)	319.26M
Book Value Per Share	3.97
Working Capital	315.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.21 million and capital expenditures -$325,000, giving a free cash flow of -$81.54 million.

Operating Cash Flow	-81.21M
Capital Expenditures	-325,000
Free Cash Flow	-81.54M
FCF Per Share	-$1.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATXS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-86.44%
Shareholder Yield	n/a
Earnings Yield	-29.30%
FCF Yield	-25.35%

Analyst Forecast

The average price target for ATXS is $26.60, which is 399.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.60
Price Target Difference	399.06%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.20%

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2021. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Aug 20, 2021
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1